{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:40:24Z","timestamp":1794962424111,"version":"4.9.1"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2020,9,10]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Like other adipokines, omentin-1 is secreted from visceral adipose tissue and plays a vital\nrole in the development of chronic inflammatory diseases, including cardiovascular events. Recent\nstudies have shown that circulating omentin-1 levels are associated with various metabolic risk\nfactors, such as high blood pressure, increased waist circumference, dyslipidemia, and glucose intolerance.\nThe decrease in serum omentin level is an independent predictor of Coronary Artery Disease\n(CAD) and is associated with the severity of this disease. Since there is no relevant review in\nthe literature, we aimed to summarize the studies on the relationship between omentin-1 and CAD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x16666200511085304","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:54:23Z","timestamp":1589226863000},"page":"198-201","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-2562","authenticated-orcid":true,"given":"Lutfu","family":"Askin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-7320","authenticated-orcid":true,"given":"Hakan","family":"Duman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Recep Tayyip Erdogan University Medicine of Faculty, Rize, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-9434","authenticated-orcid":true,"given":"Ali","family":"Ozy\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Recep Tayyip Erdogan University Medicine of Faculty, Rize, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-2048","authenticated-orcid":true,"given":"Okan","family":"Tanriverdi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-4275","authenticated-orcid":true,"given":"Serdar","family":"Turkmen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.dib.2015.11.065","volume":"6","author":"Saely C.H.","year":"2015","unstructured":"Saely C.H.; Leiherer A.; Muendlein A.; Coronary patients with high plasma omentin are at a higher cardiovascular risk. Data Brief 2015,6,158-161","journal-title":"Data Brief"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbaexp.2005.11.005","volume":"1732","author":"Sch\u00e4ffler A.","year":"2005","unstructured":"Sch\u00e4ffler A.; Neumeier M.; Herfarth H.; Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005,1732(1-3),96-102","journal-title":"Biochim Biophys Acta"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","volume":"290","author":"Yang R.Z.","year":"2006","unstructured":"Yang R.Z.; Lee M.J.; Hu H.; Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006,290(6),E1253-E1261","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.diabres.2015.06.008","volume":"110","author":"Kocijancic M.","year":"2015","unstructured":"Kocijancic M.; Vujicic B.; Racki S.; Cubranic Z.; Zaputovic L.; Dvornik S.; Serum omentin-1 levels as a possible risk factor of mortality in patients with diabetes on haemodialysis. Diabetes Res Clin Pract 2015,110(1),44-50","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=5","first-page":"455","volume":"33","author":"Onur I.","year":"2014","unstructured":"Onur I.; Oz F.; Yildiz S.; A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease. Int Angiol 2014,33(5),455-460","journal-title":"Int Angiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/1354750X.2011.622789","volume":"16","author":"Shang F.J.","year":"2011","unstructured":"Shang F.J.; Wang J.P.; Liu X.T.; Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011,16(8),657-662","journal-title":"Biomarkers"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2459\/JCM.0000000000000053","volume":"16","author":"Kadoglou N.P.","year":"2015","unstructured":"Kadoglou N.P.; Tahmatzidis D.K.; Giannakoulas C.; Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown) 2015,16(5),341-346","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/db06-1506","volume":"56","author":"de Souza Batista C.M.","year":"2007","unstructured":"de Souza Batista C.M.; Yang R.Z.; Lee M.J.; Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007,56(6),1655-1661","journal-title":"Diabetes"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5507\/bp.2016.019","volume":"160","author":"Stejskal D.","year":"2016","unstructured":"Stejskal D.; Vaclavik J.; Smekal A.; Svobodova G.; Richterova R.; Svestak M.; Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016,160(2),219-221","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1758-5996-4-37","volume":"4","author":"Shibata R.","year":"2012","unstructured":"Shibata R.; Ouchi N.; Takahashi R.; Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr 2012,4(1),37","journal-title":"Diabetol Metab Syndr"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2840-10-103","volume":"10","author":"Yoo H.J.","year":"2011","unstructured":"Yoo H.J.; Hwang S.Y.; Hong H.C.; Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011,10,103","journal-title":"Cardiovasc Diabetol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12933-015-0303-3","volume":"14","author":"Jung C.H.","year":"2015","unstructured":"Jung C.H.; Jung S.H.; Kim B.Y.; Kim C.H.; Kang S.K.; Mok J.O.; Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: A hospital-based study. Cardiovasc Diabetol 2015,14,140","journal-title":"Cardiovasc Diabetol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.atherosclerosis.2011.08.017","volume":"219","author":"Shibata R.","year":"2011","unstructured":"Shibata R.; Ouchi N.; Kikuchi R.; Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011,219(2),811-814","journal-title":"Atherosclerosis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2015.10.100","volume":"244","author":"Saely C.H.","year":"2016","unstructured":"Saely C.H.; Leiherer A.; Muendlein A.; High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis 2016,244,38-43","journal-title":"Atherosclerosis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11255-016-1275-2","volume":"48","author":"Kocijancic M.","year":"2016","unstructured":"Kocijancic M.; Cubranic Z.; Vujicic B.; Racki S.; Dvornik S.; Zaputovic L.; Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients. Int Urol Nephrol 2016,48(7),1145-1154","journal-title":"Int Urol Nephrol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1475-2840-13-84","volume":"13","author":"Narumi T.","year":"2014","unstructured":"Narumi T.; Watanabe T.; Kadowaki S.; Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc Diabetol 2014,13,84","journal-title":"Cardiovasc Diabetol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/cvr\/cvv208","volume":"108","author":"Gaborit B.","year":"2015","unstructured":"Gaborit B.; Venteclef N.; Ancel P.; Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res 2015,108(1),62-73","journal-title":"Cardiovasc Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12933-016-0406-5","volume":"15","author":"Du Y.","year":"2016","unstructured":"Du Y.; Ji Q.; Cai L.; Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol 2016,15,90","journal-title":"Cardiovasc Diabetol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.atherosclerosis.2013.12.005","volume":"233","author":"Verhagen S.N.","year":"2014","unstructured":"Verhagen S.N.; Buijsrogge M.P.; Vink A.; van Herwerden L.A.; van der Graaf Y.; Visseren F.L.; Secretion of adipocytokines by perivascular adipose tissue near stenotic and non-stenotic coronary artery segments in patients undergoing CABG. Atherosclerosis 2014,233(1),242-247","journal-title":"Atherosclerosis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncpcardio0319","volume":"2","author":"Iacobellis G.","year":"2005","unstructured":"Iacobellis G.; Corradi D.; Sharma A.M.; Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005,2(10),536-543","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/sj.ijo.0803726","volume":"32","author":"Cheng K.H.","year":"2008","unstructured":"Cheng K.H.; Chu C.S.; Lee K.T.; Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes 2008,32(2),268-274","journal-title":"Int J Obes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1152\/ajpendo.00572.2004","volume":"290","author":"Yang R-Z.","year":"2006","unstructured":"Yang R-Z.; Lee M-J.; Hu H.; Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006,290,1253-1261","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059697","volume":"8","author":"Greulich S.","year":"2013","unstructured":"Greulich S.; Chen W.J.; Maxhera B.; Cardioprotective properties of omentin-1 in type 2 diabetes: Evidence from clinical and in vitro studies. PLoS One 2013,8(3)","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cvr\/cvw016","volume":"110","author":"Watanabe K.","year":"2016","unstructured":"Watanabe K.; Watanabe R.; Konii H.; Counteractive effects of omentin-1 against atherogenesis. Cardiovasc Res 2016,110(1),118-128","journal-title":"Cardiovasc Res"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1161\/circ.130.suppl_2.11475","volume":"130","author":"Hiramatsu-Ito M.","year":"2014","unstructured":"Hiramatsu-Ito M.; Shibata R.; Ohashi K.; Abstract 11475: overexpression of human omentin in a fat-specific manner attenuates atherosclerotic lesion formation in apoe-deficient mice. Circulation 2014,130","journal-title":"Circulation"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010073","volume":"19","author":"Zhou Y.","year":"2017","unstructured":"Zhou Y.; Zhang B.; Hao C.; Omentin-A Novel Adipokine in Respiratory Diseases. Int J Mol Sci 2017,19(1)","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbrc.2011.04.039","volume":"408","author":"Yamawaki H.","year":"2011","unstructured":"Yamawaki H.; Kuramoto J.; Kameshima S.; Usui T.; Okada M.; Hara Y.; Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011,408(2),339-343","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2012.04.033","volume":"686","author":"Kazama K.","year":"2012","unstructured":"Kazama K.; Usui T.; Okada M.; Hara Y.; Yamawaki H.; Omentin plays an anti-inflammatory role through inhibition of TNF-\u03b1-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 2012,686(1-3),116-123","journal-title":"Eur J Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jpm9020030","volume":"9","author":"Jha C.K.","year":"2019","unstructured":"Jha C.K.; Mir R.; Elfaki I.; Evaluation of the association of omentin 1 rs2274907 A>T and rs2274908 G>A gene polymorphisms with coronary artery disease in indian population: A case control study. J Pers Med 2019,9(2),9","journal-title":"J Pers Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0218492317699752","volume":"25","author":"Jamshidi J.","year":"2017","unstructured":"Jamshidi J.; Ghanbari M.; Asnaashari A.; Jafari N.; Valizadeh G.A.; Omentin Val109Asp polymorphism and risk of coronary artery disease. Asian Cardiovasc Thorac Ann 2017,25(3),199-203","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref=31","first-page":"1128","volume":"33","author":"Nazar S.","year":"2017","unstructured":"Nazar S.; Zehra S.; Azhar A.; Association of single Nucleotide Missence Polymorphism Val109Asp of Omentin-1 gene and coronary artery disease in Pakistani population: Multicenter study. Pak J Med Sci 2017,33(5),1128-1133","journal-title":"Pak J Med Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcte.2018.05.003","volume":"13","author":"Elsaid N.H.","year":"2018","unstructured":"Elsaid N.H.; Sadik N.A.; Ahmed N.R.; Fayez S.E.; Mohammed N.A.E.; Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters. J Clin Transl Endocrinol 2018,13,14-19","journal-title":"J Clin Transl Endocrinol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MCA.0000000000000435","volume":"28","author":"Chen Q.","year":"2017","unstructured":"Chen Q.; Shang X.; Yuan M.; Liang L.; Zhong X.; Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease. Coron Artery Dis 2017,28(1),44-51","journal-title":"Coron Artery Dis"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/283021","volume":"2015","author":"Alkuraishy H.M.","year":"2015","unstructured":"Alkuraishy H.M.; Al-Gareeb A.I.; New insights into the role of metformin effects on serum omentin-1 levels in acute myocardial infarction: Cross-sectional study. Emerg Med Int 2015,2015","journal-title":"Emerg Med Int"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.5551\/jat.37440","volume":"24","author":"Zhou J.P.","year":"2017","unstructured":"Zhou J.P.; Tong X.Y.; Zhu L.P.; Plasma omentin-1 level as a predictor of good coronary collateral circulation. J Atheroscler Thromb 2017,24(9),940-948","journal-title":"J Atheroscler Thromb"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1074\/jbc.M111.261818","volume":"287","author":"Maruyama S.","year":"2012","unstructured":"Maruyama S.; Shibata R.; Kikuchi R.; Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J Biol Chem 2012,287(1),408-417","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature10507","volume":"479","author":"Takeda Y.","year":"2011","unstructured":"Takeda Y.; Costa S.; Delamarre E.; Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011,479(7371),122-126","journal-title":"Nature"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cvr\/cvw040","volume":"110","author":"De Jager S.C.","year":"2016","unstructured":"De Jager S.C.; Pasterkamp G.; Atheroprotective properties of human Omentin-1 in experimental atherosclerosis. Cardiovasc Res 2016,110(1),1-3","journal-title":"Cardiovasc Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"856","DOI":"10.5551\/jat.47043","volume":"26","author":"Zhu Y.","year":"2019","unstructured":"Zhu Y.; Hu C.; Du Y.; Time-dependent change in omentin-1 level correlated with early improvement of myocardial function in patients with first anterior st-segment elevation myocardial infarction after primary percutaneous coronary intervention. J Atheroscler Thromb 2019,26(10),856-867","journal-title":"J Atheroscler Thromb"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.12659\/MSM.898202","volume":"22","author":"Tao S.","year":"2016","unstructured":"Tao S.; Huang Y.Q.; Cai A.P.; Association of serum omentin-1 concentrations with the presence of atrial fibrillation. Med Sci Monit 2016,22,4749-4754","journal-title":"Med Sci Monit"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/0003319713511322","volume":"65","author":"Onur I.","year":"2014","unstructured":"Onur I.; Oz F.; Yildiz S.; Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology 2014,65(10),896-900","journal-title":"Angiology"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181837","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181837\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T15:10:42Z","timestamp":1609773042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181837\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x16666200511085304","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}